Wuhan Di'ao Pharmaceutical Co., Ltd. | Pharmaceutical Manufacturer Profile & Drug Portfolio

Lentinus edodes polysaccharide tablets

This product is mannan peptide, which is a combination of α-bonded mannose and peptide. The polysaccharide part is mainly mannose, followed by galactose, glucose, xylose and fucose, with a ratio of 74:12:12:1:1. The peptide chain is composed of 18 L-type amino acids such as aspartic acid, serine, lysine, and glutamic acid.

Name	Description	Content	CAS NO.	Registered Holders
Mannatide	Immunoenhancers can enhance the host's ability to resist viruses, tumors and bacterial infections by activating the body's immune system, and can reduce the toxicity of tumor chemotherapy drugs. More Immunoenhancers can enhance the host's ability to resist viruses, tumors and bacterial infections by activating the body's immune system, and can reduce the toxicity of tumor chemotherapy drugs.		613263-58-4	5

Lentinus edodes polysaccharide tablets

This product is mannan peptide, which is a combination of α-bonded mannose and peptide. The polysaccharide part is mainly mannose, followed by galactose, glucose, xylose and fucose, with a ratio of 74:12:12:1:1. The peptide chain is composed of 18 L-type amino acids such as aspartic acid, serine, lysine, and glutamic acid.

Name	Description	Content	CAS NO.	Registered Holders
Mannatide	Immunoenhancers can enhance the host's ability to resist viruses, tumors and bacterial infections by activating the body's immune system, and can reduce the toxicity of tumor chemotherapy drugs. More Immunoenhancers can enhance the host's ability to resist viruses, tumors and bacterial infections by activating the body's immune system, and can reduce the toxicity of tumor chemotherapy drugs.		613263-58-4	5

Camphor Mint Willow Fat Cream

This product is a compound preparation, each gram containing 50 mg of camphor, 50 mg of menthol, and 50 mg of methyl salicylate.

Name	Description	Content	CAS NO.	Registered Holders
D-CAMPHOR	Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects More Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects	50mg	464-49-3	2
DL-Menthol	Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects More Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects	50mg	89-78-1	8
Methyl salicylate	Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects More Skin irritant, can improve local blood circulation to relieve swelling, and has mild antipruritic, analgesic and anti-inflammatory effects	50mg	119-36-8	19

Terbinafine Hydrochloride Cream

Each gram contains 0.01 gram of the main ingredient, terbinafine hydrochloride.

Name	Description	Content	CAS NO.	Registered Holders
Terbinafine Hydrochloride	No specific pharmacological effects mentioned More No specific pharmacological effects mentioned	0.01g	78628-80-5	70

Trapidil Tablets

Active ingredient: Trapidil.

Name	Description	Content	CAS NO.	Registered Holders
7-(DIETHYLAMINO)-5-METHYL-S-TRIAZOLO[1,5-A]PYRIMIDINE	It can inhibit the activity of cAMP phosphodiesterase, and has a stronger effect on dilating coronary arteries than nitroglycerin, which is beneficial to the establishment of collateral circulation; it can inhibit the synthesis of thromboxane A (TXA2), promote the production of prostacyclin (PGI2), dilate peripheral arteries and veins, inhibit platelet aggregation, prevent platelet aggregation induced by arachidonic acid and platelets themselves, and disaggregate the formed aggregations; it can also competitively antagonize platelet-derived growth factor (PDGF) receptors, inhibiting the growth of smooth muscle cells. More It can inhibit the activity of cAMP phosphodiesterase, and has a stronger effect on dilating coronary arteries than nitroglycerin, which is beneficial to the establishment of collateral circulation; it can inhibit the synthesis of thromboxane A (TXA2), promote the production of prostacyclin (PGI2), dilate peripheral arteries and veins, inhibit platelet aggregation, prevent platelet aggregation induced by arachidonic acid and platelets themselves, and disaggregate the formed aggregations; it can also competitively antagonize platelet-derived growth factor (PDGF) receptors, inhibiting the growth of smooth muscle cells.		15421-84-8	3